George Simeon

CIK 000159511712 companiesREDWOOD CITY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001595117

Recent Transactions

50 trades

Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2026-06-10+37,000→ 37,000 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2026-06-09+30,000→ 30,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2026-06-05+13,000→ 13,000 total
Purchase
CRISPR Therapeutics AG$CRSP
Common Shares
2025-07-16$52.03/sh+22,319→ 238,897 total
Purchase
CRISPR Therapeutics AG$CRSP
Common Shares
2025-07-16$52.03/sh+960,983→ 1,730,179 total
Purchase
CRISPR Therapeutics AG$CRSP
Common Shares
2025-07-16$52.03/sh+6,510→ 69,687 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2025-06-10+19,000→ 19,000 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2025-06-05+46,000→ 46,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2025-06-05+13,000→ 13,000 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2024-06-13+22,500→ 22,500 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2024-06-13+19,000→ 19,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to buy)
2024-05-30+13,000→ 13,000 total
Purchase
Nkarta, Inc.$NKTX
Common Stock
2024-03-27$10.00/sh+1,548,341→ 1,548,341 total
Purchase
Nkarta, Inc.$NKTX
Common Stock
2024-03-27$10.00/sh+451,659→ 451,659 total
Award
CRISPR Therapeutics AG$CRSP
Common Shares
2024-02-27$71.50/sh+769,196→ 769,196 total
Award
CRISPR Therapeutics AG$CRSP
Common Shares
2024-02-27$71.50/sh+63,177→ 63,177 total
Award
CRISPR Therapeutics AG$CRSP
Common Shares
2024-02-27$71.50/sh+216,578→ 216,578 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2023-06-08+13,000→ 13,000 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2023-06-07+22,500→ 22,500 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2023-05-31+15,000→ 15,000 total
Purchase
Design Therapeutics, Inc.$DSGN
Common Stock
2022-12-20$8.14/sh+40,000→ 6,526,476 total
Purchase
Design Therapeutics, Inc.$DSGN
Common Stock
2022-12-19$8.63/sh+360,000→ 6,486,476 total
Purchase
Design Therapeutics, Inc.$DSGN
Common Stock
2022-12-16$8.28/sh+500,000→ 6,126,476 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Common Stock
2022-08-17$76.00/sh−2,253,660→ 0 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-08-17−8,500→ 0 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-08-17−8,500→ 0 total
Disposition to Issuer
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2022-08-17−15,000→ 0 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2022-06-15+15,000→ 15,000 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2022-06-09+12,000→ 12,000 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2022-06-08+16,000→ 16,000 total
Purchase
Nkarta, Inc.$NKTX
Common Stock
2022-04-28$15.00/sh+666,667→ 666,667 total
Purchase
Nkarta, Inc.$NKTX
Common Stock
2022-04-28$15.00/sh+666,666→ 666,666 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2021-06-13+16,511→ 16,511 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2021-06-10+10,000→ 10,000 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2021-06-02+8,500→ 8,500 total
Conversion
Design Therapeutics, Inc.$DSGN
Common Stock
2021-03-30+4,439,839→ 4,439,839 total
Conversion
Design Therapeutics, Inc.$DSGN
Series B Preferred Stock
2021-03-30−1,526,718→ 0 total
Conversion
Design Therapeutics, Inc.$DSGN
Common Stock
2021-03-30+936,637→ 5,376,476 total
Purchase
Design Therapeutics, Inc.$DSGN
Common Stock
2021-03-30$20.00/sh+250,000→ 5,626,476 total
Conversion
Design Therapeutics, Inc.$DSGN
Series A Preferred Stock
2021-03-30−7,236,938→ 0 total
Award
Design Therapeutics, Inc.$DSGN
Stock Option (right to buy)
2021-03-25+15,000→ 15,000 total
Disposition to Issuer
Principia Biopharma Inc.
Warrant
2020-09-28−28,623→ 0 total
Disposition from Tender
Principia Biopharma Inc.
Common Stock
2020-09-28$100.00/sh−2,982,855→ 0 total
Disposition to Issuer
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-09-28−20,475→ 0 total
Disposition to Issuer
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-09-28−10,240→ 0 total
Disposition to Issuer
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-09-28−10,240→ 0 total
Award
Nkarta, Inc.$NKTX
Stock Option (right to buy)
2020-07-09+10,700→ 10,700 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2020-06-15+8,500→ 8,500 total
Award
CRISPR Therapeutics AG$CRSP
Stock Option (Right to Buy)
2020-06-11+15,000→ 15,000 total
Award
Principia Biopharma Inc.
Director Stock Option (right to buy)
2020-06-04+10,240→ 10,240 total

Companies

Recent Filings

Address

929 MAIN STREET SUITE 200

REDWOOD CITY, CA, 94063

View on SEC.gov